More than 800 Tina’s Wish supporters came together during Ovarian Cancer Awareness Month to raise $2 MILLION for critical scientific research into the early… View more
Though there is still no early screening for ovarian cancer, genetic testing is one way to discover if an individual is at… View more
Through their collaborative efforts, Tina’s Wish Researchers, Daniel Heller, PhD, MSKCC, Ryan Williams, PhD, MSKCC and Douglas Levine, NYU Langone Medical Center… View more
“Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the… View more
Joan Janssen, an ovarian cancer patient at Dana-Farber, speaks about the development of targeted therapies and how she is using them to… View more
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute, including Tina’s Wish researchers, Dipanjan Chowdhury, PhD, and Kevin Elias, MD, are… View more
